EFSD and Novo Nordisk A/S

Programme for Diabetes Research

in Europe

Request for Applications

 

Deadline for submission of applications: 1 February 2016


Background

The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application.

Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs over 40,000 employees in 75 countries, and markets its products in more than 180 countries.

Programme and Research Focus

To achieve the goals and objectives of this Programme, EFSD and Novo Nordisk invite applications by issuing this “Request for Applications” (RFA).

The EFSD/Novo Nordisk Programme for Diabetes Research in Europe Programme will accept applications from all fields of diabetes research including both basic and clinical research.

Mechanisms of Support and Review

Research will be supported through the award of grants of up to Euro 100,000 for basic research projects and Euro 400,000 for clinical research projects.The definition of clinical research is a study performed in human individuals with focus on clinically relevant and diabetes-related outcomes.

The duration of each award will depend upon the needs of the project and as justified in the application. EFSD may, at the suggestion of the Review Committee, recommend an award in a different amount from that requested, but which is considered more appropriate for the proposed studies.

Applicants having a funding requirement larger than that specified above are also invited to apply to this Programme, particularly if this relates to a clinical project; in this case, the relevant funding requirements should be well justified in the budget section of the application form for special consideration by the review committee.

Studies forming part of a larger project will be considered for funding but this will need to be well justified in the application (see Review Considerations).

Applications for an EFSD/Novo Nordisk grant are invited from single non-profit institutions or groups of such institutions from Europe and associated countries. The principal investigator and any co-investigators must be normally employed at a non-profit institution and the study must be performed at their place of work.

Applications will be subject to a scientific review by a specialised and independent ad hoc committee. It is anticipated that applications will be received, reviewed and approved for funding by May 2016.

Prior to any final decision on funding, and in order to offer applicants the opportunity to benefit from the review process, EFSD reserve the right to request revision to applications in accordance with the recommendations of the Review Committee.

Research Grant Applications

Applications for research grants may be subjected to pre-review (or triage) procedures.  In this event, any application rejected at pre-review will not be subject to a complete scientific review, and no feedback report will be provided to the applicant.

The deadlines for receipt of research grant applications for funding is 1 February 2016.

All budgets are to be prepared in Euro.  For countries in which the Euro is not the common currency, the exchange rate (between the Euro and the local currency in the country where the work is to be performed) used for calculating the Euro budget must be mentioned under “Budget Justification”.  

Application forms may be downloaded from here:

Application Form

All applications must be prepared on the official forms and completed in strict accordance with the detailed instructions to be found on these forms.  Applications which do not comply with the instructions given in the application form will not be considered for review.

Please send your application as one complete PDF email attachment to the following address by 12:00 midday (CET) on the deadline date:

This email address is being protected from spambots. You need JavaScript enabled to view it. This email address is being protected from spambots. You need JavaScript enabled to view it.

Review Considerations

Completed applications will be evaluated in accordance with the criteria stated below for scientific/technical merit by an appropriate scientific committee.

Review criteria are as follows:

  • Significance: Does the study address an important problem?  If the aims of the application are achieved, how will scientific knowledge be advanced?  What will be the effect of the proposed studies on the concepts or methods that drive this field?
  • Approach: Are the conceptual framework, design, methods and analyses adequately developed, well integrated, and appropriate to the aims of the project?  Does the applicant acknowledge potential problem areas and consider alternative tactics?
  • Innovation: Does the project employ novel concepts, approaches or methods?  Are the aims original and innovative?  Does the project challenge existing paradigms or develop new methodologies or technologies?
  • Investigator: Is the investigator appropriately trained and well suited to carry out this work?  Is the work proposed appropriate to the experience level of the principal investigator and other researchers (if any)?
  • Environment: Does the scientific environment in which the work will be done contribute to the probability of success?  Do the proposed experiments take advantage of unique features of the scientific environment or employ useful collaborative arrangements?  Is there evidence of institutional support?
  • Budget: Is the requested budget appropriate for the proposed study? Is the requested duration suitable for completion of the project?
  • Contribution towards a larger research project: Is the work described in the application intended as part of a larger project? If so, is there any overlap? Is there a clear explanation how the new work will contribute towards the overall success of that larger project?

Reporting Requirements and Approval of Funding

All investigators funded by this Programme are required to submit a scientific progress report at the end of the project period. For those projects where funding is distributed over a period of more than one year, interim progress reports will also be required. Such reports will be subject to assessment prior to the release of any further funds.

Investigators must provide EFSD with copies of papers accepted for publication, and must acknowledge the support of the Programme in all written material by use of the phrase: "supported by an EFSD/Novo Nordisk research grant".

Competitive Renewal

Applications for renewal of a research programme award will be accepted on a competitive basis, with the same review process as described in this Announcement. Such applications will thus be considered in the same fashion as all other new applications received for review and without any special priority.

Schedule

Announcement:            October 2015

Application Deadline:   1 February 2016

Anticipated Award:       May 2016

 

 

 

Enquiries should be directed to:

 

European Foundation for the

Study of Diabetes

Rheindorfer Weg 3

40591 Düsseldorf, Germany

Tel: + 49-211-75 84 69-0

Fax: + 49-211-75 84 69 29

E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.